Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.17 -3.9%
Financial Fact:
Diluted weighted average common shares outstanding: 15.08M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Diluted weighted average common shares outstanding: 15.08M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
